GXE:ETR
Lakefront Biotherapeutics NV
€26,48
arrow_upward
+0,46%(+0,12) 1D
12 Okt., 09:04:31 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€26,48
High
€26,48
Low
€26,48
Mkt. cap
1,74 mjd
Avg. vol.
523,00
Volume
38,00
P/E ratio
2,93
52-wk high
€30,02
52-wk low
€22,84
EPS
€9,05
No. of employees
196
Open
€26,48
High
€26,48
Low
€26,48
Mkt. cap
1,74 mjd
Avg. vol.
523,00
Volume
38,00
P/E ratio
2,93
52-wk high
€30,02
52-wk low
€22,84
EPS
€9,05
No. of employees
196
News stories
From web sources and news partners
Yahoo Finance
·
1 uur gelede
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Sahi
·
44 minute gelede
Black Box Shows Interest In Nasdaq Listed Aeries Technology Reporting $70 Million FY26 Revenue
The Motley Fool
·
9 minute gelede
Vanguard's S&P 500 Fund Has Raised Its Payout 71% Since 2016. Its Yield Has Nearly Halved.
Bloomberg.com
·
1 uur gelede
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV